|
HK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79567472002873E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.52180540075642E-11 |
| Normal-vs-Stage2 |
2.18219999958968E-07 |
| Normal-vs-Stage3 |
1.25210000001541E-06 |
| Normal-vs-Stage4 |
1.839520E-04 |
| Stage1-vs-Stage2 |
6.265500E-02 |
| Stage1-vs-Stage3 |
4.997600E-01 |
| Stage1-vs-Stage4 |
1.114440E-01 |
| Stage2-vs-Stage3 |
2.668400E-02 |
| Stage2-vs-Stage4 |
6.704800E-01 |
| Stage3-vs-Stage4 |
6.824200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12549985892474E-11 |
| Normal-vs-AfricanAmerican |
2.219700E-02 |
| Normal-vs-Asian |
2.10999999999961E-05 |
| Caucasian-vs-AfricanAmerican |
6.892200E-01 |
| Caucasian-vs-Asian |
6.164200E-01 |
| AfricanAmerican-vs-Asian |
4.882000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.35020000419695E-08 |
| Normal-vs-Female |
1.72462044645272E-12 |
| Male-vs-Female |
5.874200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85899995397421E-09 |
| Normal-vs-Age(41-60Yrs) |
4.1376002624105E-10 |
| Normal-vs-Age(61-80Yrs) |
3.21540000003395E-06 |
| Normal-vs-Age(81-100Yrs) |
2.101700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.783000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.509000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.530000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.549400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.313200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.171600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.810100E-02 |
| Classical-VS-Follicular |
1.192970E-01 |
| Classical-VS-Other |
4.871400E-01 |
| Classical-VS-Normal |
5.85087533977457E-14 |
| Tall-VS-Follicular |
5.030200E-01 |
| Tall-VS-Other |
9.767200E-01 |
| Tall-VS-Normal |
1.442930E-03 |
| Follicular-VS-Other |
6.984200E-01 |
| Follicular-VS-Normal |
2.23709999969124E-07 |
| Other-VS-Normal |
2.930200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.69219987916836E-10 |
| Normal-vs-N1 |
2.037400E-04 |
| N0-vs-N1 |
1.319750E-01 |
|
|
